These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Dexamethasone intravitreal implant for treatment of persistent macular oedema in Birdshot retinochoroidopathy.
    Author: Rivera de Zea P, García-Ben A, Rachwani Parshotam N, García-Campos JM.
    Journal: Arch Soc Esp Oftalmol; 2016 Mar; 91(3):138-41. PubMed ID: 26703205.
    Abstract:
    CLINICAL CASE: The case is reported of a 32 year-old man with a bilateral cystoid macular oedema and serous macular detachment due to birdshot retinochoroidopathy. An intravitreal implant of 0.7 mg dexamethasone (Ozurdex®, Allergan) was performed on both eyes, after a partial response of the macular oedema to oral and subtenon corticosteroids. Anatomical and visual improvements were observed and maintained after six months of follow up. DISCUSSION: Intravitreal dexamethasone implant may be a good therapeutic option in patients with macular oedema due to Birdshot retinochoroidopathy, and who were refractory or had intolerance to previous therapies.
    [Abstract] [Full Text] [Related] [New Search]